| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| C Lacroix, R Guilhaumou, J Micallef, G Bruneteau, C Desnuelle, O Bli. Cannabis for the treatment of amyotrophic lateral sclerosis: What is the patients' view? Revue neurologique. 2023-07-17. PMID:37460332. |
even if cannabis is mostly used outside medical pathways and could expose patients to complications (street and uncontrolled drugs, drug-drug interactions, adverse effects…), most of the participants reported "rational" consumption (legal cannabinoids, with only few combustion and adverse reactions). |
2023-07-17 |
2023-08-14 |
human |
| Aaron S Wolfgang, Charles W Hog. Cannabis and Cannabinoids for Pain and Posttraumatic Stress Disorder in Military Personnel and Veterans. JAMA psychiatry. 2023-07-12. PMID:37436761. |
cannabis and cannabinoids for pain and posttraumatic stress disorder in military personnel and veterans. |
2023-07-12 |
2023-08-14 |
Not clear |
| Obinna Ugwuegbu, Fahmi Shibli, Yeseong Kim, Vikram Rangan, Michael Kurin, Fares Ayoub, Stephen Ganocy, Robert Kavitt, Ronnie Fas. The Impact of Chronic Cannabis Use on Esophageal Motility in Patients Referred for Esophageal Manometry. Journal of clinical gastroenterology. 2023-07-12. PMID:37436840. |
tetrahydrocannabinol, the main psychoactive compound in cannabis, binds with high affinity to the cannabinoid 1 receptor. |
2023-07-12 |
2023-08-14 |
Not clear |
| Ahmad Shamabadi, Ali Ahmadzade, Kasra Pirahesh, Alireza Hasanzadeh, Hassan Asadigandoman. Suicidality risk after using cannabis and cannabinoids: An umbrella review. Dialogues in clinical neuroscience. vol 25. issue 1. 2023-07-10. PMID:37427882. |
suicidality risk after using cannabis and cannabinoids: an umbrella review. |
2023-07-10 |
2023-08-14 |
Not clear |
| Ahmad Shamabadi, Ali Ahmadzade, Kasra Pirahesh, Alireza Hasanzadeh, Hassan Asadigandoman. Suicidality risk after using cannabis and cannabinoids: An umbrella review. Dialogues in clinical neuroscience. vol 25. issue 1. 2023-07-10. PMID:37427882. |
this study aims to identify and appraise systematic reviews investigating suicidality after using cannabis and cannabinoids. |
2023-07-10 |
2023-08-14 |
Not clear |
| J Dochez-Arnault, C Desdoits-Lethimonier, I Matias, B Evrard, M Lagarrigue, M Toupin, A Lardenois, F Chalmel, S Mazaud-Guittot, N Dejucq-Rainsford, A Gely-Perno. Expression of the endocannabinoid system and response to cannabinoid components by the human fetal testis. BMC medicine. vol 21. issue 1. 2023-07-10. PMID:37430350. |
cannabis action is mediated by the endocannabinoid system (ecs), which expression is well established in the brain but unknown in the developing testis. |
2023-07-10 |
2023-08-14 |
human |
| Fabiana Russo, Maria Angela Vandelli, Giuseppe Biagini, Martin Schmid, Livio Luongo, Michela Perrone, Federica Ricciardi, Sabatino Maione, Aldo Laganà, Anna Laura Capriotti, Alfonso Gallo, Luigi Carbone, Elisabetta Perrone, Giuseppe Gigli, Giuseppe Cannazza, Cinzia Citt. Synthesis and pharmacological activity of the epimers of hexahydrocannabinol (HHC). Scientific reports. vol 13. issue 1. 2023-07-08. PMID:37422571. |
cannabis is a multifaceted plant with numerous therapeutic properties on one hand, and controversial psychotropic activities on the other hand, which are modulated by cb1 endocannabinoid receptors. |
2023-07-08 |
2023-08-14 |
Not clear |
| Lianne Hagg, Sarah Leung, Roxane Car. Characterizing the Use of Nabiximols (Δ9-Tetrahydrocannabinol-Cannabidiol) Buccal Spray in Pediatric Patients. The Canadian journal of hospital pharmacy. vol 76. issue 3. 2023-07-06. PMID:37409141. |
nabiximols is a commercially available cannabinoid buccal spray containing 2.7 mg Δ9-tetrahydrocannabinol (thc) and 2.5 mg cannabidiol (cbd) per spray. |
2023-07-06 |
2023-08-14 |
Not clear |
| Julie K Johnson, Alexander Colb. History of Cannabis Regulation and Medicinal Therapeutics: It's Complicated. Clinical therapeutics. vol 45. issue 6. 2023-07-06. PMID:37414502. |
from its origins as a therapeutic agent in 2800 bc china, to the current knowledge on cannabinoids and the cannabinoid system, to the complex status of cannabis regulation across continents-knowledge gained from the history of cannabis use can inform research on cannabis-based treatments for patients with medical conditions that remain challenging in 21st century medicine, warranting research and evidence-based policy options. |
2023-07-06 |
2023-08-14 |
Not clear |
| Edward Y Liu, Kenneth L McCall, Brian J Pipe. Pronounced State-Level Disparities in Prescription of Cannabinoids to Medicaid Patients. Medical cannabis and cannabinoids. vol 6. issue 1. 2023-07-05. PMID:37404688. |
this study examined medicaid claims for two fda-approved prescription cannabinoids, dronabinol and cannabidiol, approved in 1985 and 2018, respectively, from 2016-2020 to better understand the pharmacoepidemiologic trends and distribution of these drugs in us medicaid amidst the increasing use of non-pharmaceutical formulations of cannabis. |
2023-07-05 |
2023-08-14 |
Not clear |
| Alannah Miranda, Elizabeth Peek, Sonia Ancoli-Israel, Jared W Young, William Perry, Arpi Minassia. The Role of Cannabis and The Endocannabinoid System in Sleep Regulation and Cognition: A Review of Human and Animal Studies. Behavioral sleep medicine. 2023-07-04. PMID:37401160. |
the role of cannabis and the endocannabinoid system in sleep regulation and cognition: a review of human and animal studies. |
2023-07-04 |
2023-08-14 |
human |
| Odunayo Anthonia Taiwo, Oluwatosin Adebisi Dosumu, Adewale Segun James, Emmanuel Ifeanyichukwu Ugwor, Oluwafemi Adeleke Ojo, Gabriel Adewunmi Dedeke, Oladipo Ademuyiw. Pre-puberty cannabichromene exposure modulates reproductive function via alteration of spermatogenesis, steroidogenesis, and eNOS pathway metabolites. Toxicology reports. vol 10. 2023-07-03. PMID:37396845. |
cannabis and cannabinoids affect almost every system of the body and exert systemic effects such as alterations in memory and cognitive functions, neurotransmission impediment, as well as obstruction of endocrine and reproductive system functions. |
2023-07-03 |
2023-08-14 |
Not clear |
| Nicolás Fernández, Marcello Gian Cappello, Patricia Noemí Quirog. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic science international. vol 349. 2023-07-01. PMID:37392612. |
an assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in argentina. |
2023-07-01 |
2023-08-14 |
Not clear |
| Nicolás Fernández, Marcello Gian Cappello, Patricia Noemí Quirog. An assessment of qualitative and quantitative cannabinoids analysis in selected commercially available cannabis oils in Argentina. Forensic science international. vol 349. 2023-07-01. PMID:37392612. |
in recent years, the therapeutic use of cannabis products, especially cannabis oils, has increased significantly, due to the pharmacological potential of their cannabinoids, for the treatment of conditions, such as pain management, cancer, and epilepsy. |
2023-07-01 |
2023-08-14 |
Not clear |
| Zhe Yang, Jian-Xia Lyu, Yi-di Wu, Li-Wei Jiang, Dong-Mei L. [Simultaneous determination of five indole/indazole amide-based synthetic cannabinoids in electronic cigarette oil by ultra performance liquid chromatography]. Se pu = Chinese journal of chromatography. vol 41. issue 7. 2023-06-30. PMID:37387281. |
synthetic cannabinoids (scs), which are considered some of the most widely abused new psychoactive substances available today, are much more potent than natural cannabis and display greater efficacy. |
2023-06-30 |
2023-08-14 |
Not clear |
| Rachel S Wightman, Jane Metrik, Timmy R Lin, Alexandra B Collins, Francesca L Beaudoi. Cannabinoid hyperemesis syndrome: clinical trajectories and patterns of use three months following a visit to the emergency department. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine. 2023-06-30. PMID:37387520. |
cannabinoid hyperemesis syndrome (chs) is a clinical condition of cyclic vomiting, nausea, and abdominal pain associated with chronic cannabis use. |
2023-06-30 |
2023-08-14 |
Not clear |
| Douglas da Silva Rodrigues, Adria Santos Bastos Soares, Claudia Dizioli Franco Buen. The use of cannabinoids in children with epilepsy: A systematic review. Epilepsy & behavior : E&B. vol 145. 2023-06-30. PMID:37390729. |
cannabinoids, especially cannabidiol, began to be studied to contribute to the treatment of these syndromes, configuring an expanding research area. |
2023-06-30 |
2023-08-14 |
Not clear |
| Alice Zucchi, Elisa Innocenzi, Angelo Onorato, Susanna Dolci, Ambra Colopi, Carmela Rita Balistreri, Paola Grimald. PRENATAL EXPOSURE TO CB Mechanisms of ageing and development. 2023-06-29. PMID:37385302. |
the biological effects of cannabis are mediated by two cannabinoid receptors, cb |
2023-06-29 |
2023-08-14 |
Not clear |
| Eric R Larson, Alexandra B Moussa-Tooks, Rachel L Tullar, Amanda R Bolbecker, Brian F O'Donnell, William P Hetrick, Krista M Wisne. Sex differences in neuroendocrine, sympathetic nervous system, and affect responses to acute stress in cannabis users. Psychopharmacology. 2023-06-27. PMID:37367968. |
however, the role of biological sex in this interaction between cannabis use and stress is poorly understood, despite sex differences in neurobiological stress responsivity, endocannabinoid signaling, and clinical correlates of cannabis use. |
2023-06-27 |
2023-08-14 |
Not clear |
| Jack Wilson, Katherine L Mills, Matthew Sunderland, Tom P Freeman, Maree Teesson, Paul S Haber, Christina Mare. Different Tokes for Different Folks: Use of Cannabis Products Among a Longitudinal Cohort of People with Heroin Dependence. International journal of mental health and addiction. 2023-06-26. PMID:37363767. |
co-occurring cannabis use is common among those with opioid use disorder (oud), but the extent to which it is harmful may be due to its preparation and concentration of various cannabinoids. |
2023-06-26 |
2023-08-14 |
human |